Trial Profile
A Study Assessing the Technical Feasibility of Ferumoxytol-Enhanced Magnetic Resonance Angiography for Vascular Access Mapping before Transcatheter Aortic Valve Replacement in Patients with Renal Impairment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jan 2018
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Diagnostic use
- 24 Jan 2018 New trial record
- 01 Jan 2018 Results published in the Radiology Journal.